Second round of Headstart Programme 2020 – Applications are open!
EIT Health Germany is pleased to open the application process for the second round of the Headstart Programme. The EIT Health Headstart programme provides emerging companies with mentorship and funding opportunities to accelerate the development and time-to-market of innovative products and services to improve the lives of European patients and citizens. Mentored by EIT Health’s regional teams […]
Startups Meet Pharma Cohort 2020 – The Amgen MM challenge
Choosing the right treatment for Multiple Myeloma patients is challenge #5 set by Amgen and four startups are shortlisted to work with them. Sixteen startups from Germany, Austria, UK, France, Belgium, Netherlands, Ireland, Poland, Italy, Finland, Greece, Spain, Estonia and Israel have been selected for the Startups Meet Pharma 2020 cohort. This year, five challenges […]
Startups Meet Pharma Cohort 2020- The Boehringer Ingelheim challenge
Four startups were selected to tackle the Boehringer Ingelheim challenge on Portable Interstitial Lung Disease (ILD) Diagnostic Tool. Sixteen startups from Germany, Austria, UK, France, Belgium, Netherlands, Ireland, Poland, Italy, Finland, Greece, Spain, Estonia and Israel have been selected for the Startups Meet Pharma 2020 cohort. This year, five challenges have been released in collaboration […]
Startups vs COVID-19: Chatting with the winners of the Headstart COVID-19 call
Within the Headstart Programme for COVID-19 solutions, EIT Health Germany awarded 4 grants to Climedo Health, RAMPmedical, Intrepida and ScintHealth to develop products and services that will help Europe to contain, treat and manage the COVID-19 outbreak. This year EIT Health expanded the scope of the Headstart programme to assist in the immediate need for solutions […]
Startups Meet Pharma Cohort 2020: The Amgen – postMI challenge
Encourage continuity in treatment strategy and treatment optimization for post-myocardial infarction patients is the challenge #3 for this year’s Startups Meet Pharma programme set by Amgen. Sixteen startups from Germany, Austria, UK, France, Belgium, Netherlands, Ireland, Poland, Italy, Finland, Greece, Spain, Estonia and Israel have been selected for the Startups Meet Pharma 2020 cohort. This […]
Startups Meet Pharma Cohort 2020: The Beiersdorf challenge
Challenge #2 is reserved for Beiersdorf and their quest for new solutions to improve the condition of diabetic skin. Sixteen startups from Germany, Austria, UK, France, Belgium, Netherlands, Ireland, Poland, Italy, Finland, Greece, Spain, Estonia and Israel have been selected for the Startups Meet Pharma 2020 cohort. This year, five challenges have been released in […]
Startups Meet Pharma Cohort 2020 – The Bayer challenge
With the selection phase over, it is time to meet the Startups Meets Pharma cohort 2020. We break the ice with Bayer’s challenge on gene therapies, cell therapies and delivery technologies for different therapeutic areas and the startup selected for this challenge: Eukarÿs. Sixteen startups from Germany, Austria, UK, France, Belgium, Netherlands, Ireland, Poland, Italy, […]
Headstart Funding Programme 2020: 7 startups awarded with the Headstart grant
EIT Health Germany has chosen the winners of the first round of EIT Health Headstart support for 2020. Aumio, BOCAhealth, DeepSpin, Iuvando, Nia Health, Virtonomy and Zoundream, welcome to the Headstart family. The selection phase of the first round of the EIT Health Germany Headstart Programme is officially completed and seven startups were named today […]
Regional Selection of EIT Health Catapult: 6 startups move to the semi-finals
The Regional Selection of the EIT Health Catapult concluded with the selection of PhagoMed, LenioBio (BioTech), Cardilink, LivingBrain (Digital Health) PerAGraft, and Amparo (MedTech) for the semi-finals in autumn. On 26 May 2020 we hosted the Regional Selection of the EIT Health Catapult and 13 startups presented their MedTech, BioTech and Digital Health solutions during […]
Siemens Healthineers joins Covid-19 antibody testing race
Siemens Healthineers launches antibody test and molecular test kit for COVID-19 and is ready to ramp up its production capacity to more than 50 million antibody tests per month as the pandemic evolves. As a leading medical technology company, Siemens Healthineers responded quickly to the ongoing health crisis by offering a SARS-CoV-2 Molecular Test in […]
